Your browser doesn't support javascript.
loading
T cell subtype profiling measures exhaustion and predicts anti-PD-1 response.
Schillebeeckx, Ian; Earls, Jon; Flanagan, Kevin C; Hiken, Jeffrey; Bode, Alex; Armstrong, Jon R; Messina, David N; Adkins, Douglas; Ley, Jessica; Alborelli, Ilaria; Jermann, Philip; Glasscock, Jarret I.
Affiliation
  • Schillebeeckx I; Cofactor Genomics, Inc., San Francisco, CA, USA. ian@cofactorgenomics.com.
  • Earls J; Cofactor Genomics, Inc., San Francisco, CA, USA.
  • Flanagan KC; Cofactor Genomics, Inc., San Francisco, CA, USA.
  • Hiken J; Cofactor Genomics, Inc., San Francisco, CA, USA.
  • Bode A; Cofactor Genomics, Inc., San Francisco, CA, USA.
  • Armstrong JR; Cofactor Genomics, Inc., San Francisco, CA, USA.
  • Messina DN; Cofactor Genomics, Inc., San Francisco, CA, USA.
  • Adkins D; Washington University School of Medicine, Saint Louis, MO, USA.
  • Ley J; Washington University School of Medicine, Saint Louis, MO, USA.
  • Alborelli I; Department of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland.
  • Jermann P; Department of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland.
  • Glasscock JI; Cofactor Genomics, Inc., San Francisco, CA, USA.
Sci Rep ; 12(1): 1342, 2022 01 25.
Article in En | MEDLINE | ID: mdl-35079117

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: CD8-Positive T-Lymphocytes / Programmed Cell Death 1 Receptor / Neoplasms Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Sci Rep Year: 2022 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: CD8-Positive T-Lymphocytes / Programmed Cell Death 1 Receptor / Neoplasms Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Sci Rep Year: 2022 Document type: Article Affiliation country: Country of publication: